Reins expands into Canada, bringing alternative equity solutions to independent businesses
Company builds on US success by helping Canadian business owners retain key employees and prepare for succession without giving up ownership LAS VEGAS, July 20,... Read more.
Marengo Secures ESMO 2026 Oral Presentation for Key Phase 2 Invikafusp Alfa Data in PD-1-Resistant Solid Tumors and Appoints Pembrolizumab Development Leader Eric Rubin, M.D., to Scientific Advisory Board
Updated STARt-001 results will highlight invikafusp alfa’s single-agent activity in PD-1–resistant tumors using a biomarker-enrichment strategy Eric Rubin,... Read more.
MiniMed to Announce Its Fiscal Year 2027 First Quarter Financial Results
NORTHRIDGE, Calif., July 20, 2026 /PRNewswire/ — MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it expects to report... Read more.
Medtronic to announce financial results for its first quarter of fiscal year 2027
GALWAY, Ireland, July 20, 2026 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial... Read more.
Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02
FDA submissions address all feedback on clinical, CMC, and regulatory topics from the End-of-Phase 2 meeting Four AP-SA02 engineering runs completed; clinical trial... Read more.
Examinetics, a Coalesce Capital Portfolio Company, Strengthens Safety Consulting Services with Acquisitions of Progressive Safety and Jurgiel & Associates
Transactions mark the company’s fourth and fifth acquisitions to enhance safety consulting and safety compliance programs OVERLAND PARK, Kan., July 20, 2026... Read more.
BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026
TEL AVIV, Israel and OSLO, Norway, July 20, 2026 /PRNewswire/ — BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing... Read more.
Mentari Therapeutics Appoints Industry Veteran Greg Divis as Chief Executive Officer
Former Avadel CEO brings a proven track record of strategic leadership, M&A expertise, and commercial success to lead Mentari as it advances potentially best-in-class... Read more.
Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026
HOLON, Israel, July 20, 2026 /PRNewswire/ — Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational... Read more.
HIGHWAY HOLDINGS OPENS FISCAL 2027 WITH 29% YOY REVENUE GROWTH, 58% YOY GROSS PROFIT GROWTH AND RETURN TO OPERATING PROFITABILITY
Gross margin expanded approximately 800 basis points year-over-year to 42% Net income attributable to Highway Holdings shareholders increased 79% year-over-year... Read more.